Linda Holtman

755 total citations
9 papers, 621 citations indexed

About

Linda Holtman is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Linda Holtman has authored 9 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Psychiatry and Mental health and 5 papers in Oncology. Recurrent topics in Linda Holtman's work include Epilepsy research and treatment (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Linda Holtman is often cited by papers focused on Epilepsy research and treatment (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Linda Holtman collaborates with scholars based in Netherlands and Germany. Linda Holtman's co-authors include Erwin A. van Vliet, Eleonora Aronica, Jan A. Gorter, Peter M. Edelbroek, Arno Sinjewel, Jeroen C. G. den Burger, Helga E. de Vries, Claudio M. Queiroz, Anton Pekcec and Heidrun Potschka and has published in prestigious journals such as Neuroscience, Epilepsia and Neuropharmacology.

In The Last Decade

Linda Holtman

9 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Holtman Netherlands 8 291 283 172 160 147 9 621
Alexandra M. Gastens Germany 7 255 0.9× 375 1.3× 127 0.7× 363 2.3× 295 2.0× 7 700
Patrik Foerch Belgium 15 273 0.9× 192 0.7× 378 2.2× 85 0.5× 28 0.2× 16 640
Till S. Zimmer Netherlands 14 151 0.5× 76 0.3× 127 0.7× 28 0.2× 43 0.3× 22 431
Shabeesh Balan Japan 16 81 0.3× 104 0.4× 290 1.7× 71 0.4× 50 0.3× 35 577
Myung‐Soon Yang South Korea 8 153 0.5× 66 0.2× 181 1.1× 39 0.2× 40 0.3× 9 604
Bjoern Bauer United States 10 58 0.2× 49 0.2× 181 1.1× 93 0.6× 194 1.3× 16 532
David B. Hawver United States 9 155 0.5× 126 0.4× 222 1.3× 64 0.4× 17 0.1× 10 428
Mark Walzer United States 11 178 0.6× 67 0.2× 114 0.7× 54 0.3× 28 0.2× 22 432
Giulia Mazzoleni Italy 13 145 0.5× 100 0.4× 275 1.6× 44 0.3× 20 0.1× 15 719
Keisha Smith United States 9 182 0.6× 32 0.1× 195 1.1× 19 0.1× 109 0.7× 12 561

Countries citing papers authored by Linda Holtman

Since Specialization
Citations

This map shows the geographic impact of Linda Holtman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Holtman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Holtman more than expected).

Fields of papers citing papers by Linda Holtman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Holtman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Holtman. The network helps show where Linda Holtman may publish in the future.

Co-authorship network of co-authors of Linda Holtman

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Holtman. A scholar is included among the top collaborators of Linda Holtman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Holtman. Linda Holtman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Holtman, Linda, et al.. (2020). Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis. Frontiers in Neurology. 11. 591690–591690. 99 indexed citations
2.
Holtman, Linda, Erwin A. van Vliet, Chantal C.M. Appeldoorn, et al.. (2014). Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat. Epilepsy Research. 108(3). 396–404. 15 indexed citations
3.
Holtman, Linda, Erwin A. van Vliet, Eleonora Aronica, et al.. (2013). Blood plasma inflammation markers during epileptogenesis in post–status epilepticus rat model for temporal lobe epilepsy. Epilepsia. 54(4). 589–595. 40 indexed citations
4.
Vliet, Erwin A. van, Linda Holtman, Jeroen C. G. den Burger, et al.. (2012). Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood–brain barrier leakage but not microglia activation. Epilepsia. 53(7). 1254–1263. 146 indexed citations
5.
Vliet, Erwin A. van, et al.. (2011). Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy. Epilepsia. 52(7). 1319–1330. 29 indexed citations
6.
Holtman, Linda, Erwin A. van Vliet, Frank Baas, Eleonora Aronica, & Jan A. Gorter. (2011). Complement protein 6 deficiency in PVG/c rats does not lead to neuroprotection against seizure induced cell death. Neuroscience. 188. 109–116. 6 indexed citations
7.
Holtman, Linda, Erwin A. van Vliet, Peter M. Edelbroek, Eleonora Aronica, & Jan A. Gorter. (2010). Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Research. 91(1). 49–56. 74 indexed citations
8.
Holtman, Linda, et al.. (2009). Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Research. 84(1). 56–66. 96 indexed citations
9.
Vliet, Erwin A. van, Anton Pekcec, Juli Schlichtiger, et al.. (2009). COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology. 58(2). 404–412. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra M. Gastens Breakdown of academic impact, for papers by Patrik Foerch Breakdown of academic impact, for papers by Till S. Zimmer Breakdown of academic impact, for papers by Shabeesh Balan Breakdown of academic impact, for papers by Myung‐Soon Yang Breakdown of academic impact, for papers by Bjoern Bauer Breakdown of academic impact, for papers by David B. Hawver Breakdown of academic impact, for papers by Mark Walzer Breakdown of academic impact, for papers by Giulia Mazzoleni Breakdown of academic impact, for papers by Keisha Smith
Rankless by CCL
2026